UTMD Utah Medical Products, Inc.
Stable Earnings Power
B- 67.9 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
C- 47
  • 5yr Avg ROIC 11.4%
  • Operating Margin Trend -2.24 pp/yr

Capital Efficiency

Weight: 15%
B+ 79
  • 5yr Avg ROE 12.3%
  • 5yr Share-Count CAGR -3.0%

Growth Quality

Weight: 15%
F 16
  • 5yr Revenue CAGR -5.9%
  • 5yr EPS CAGR -3.7%
  • Revenue-Growth Years (5) 2/5

Cash Generation

Weight: 15%
A+ 98
  • 5yr FCF Margin 39.4%
  • 5yr FCF/NI Conversion 1.25x

Balance Sheet

Weight: 20%
A+ 100
  • Net Debt / EBITDA -5.01x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 33.78

Stability

Weight: 15%
B- 64
  • EPS Volatility (σ/μ) 0.21
  • Piotroski F-Score 7
  • Negative-Revenue Years (5) 3/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Trimming

1 of 1 gurus held; 1 trimmed.

Holders
1
Avg Δ position
-1.1%
New buys
0
Full exits
0
As of Q1 2026